Literature DB >> 25975810

Analysis of oxidative stress expressed by urinary level of biopyrrins and 8-hydroxydeoxyguanosine in patients with chronic schizophrenia.

Tsuyoshi Miyaoka1, Masa Ieda1, Sadayuki Hashioka1, Rei Wake1, Motohide Furuya1, Kristian Liaury1, Maiko Hayashida1, Keiko Tsuchie1, Ryosuke Arauchi1, Tomoko Araki1, Izuru Shioji2, Satoko Ezoe1, Ken Inoue3, Tokio Yamaguchi4, Jun Horiguchi1.   

Abstract

AIMS: Previous studies have supported the claim that psychological stress induces the production of reactive oxygen species. Several authors have suggested that patients with psychiatric disorders show high levels of oxidative stress markers. We examined different oxidative stress markers in patients with chronic schizophrenia.
METHODS: This study included 29 patients with chronic schizophrenia and 30 healthy volunteers. The concentration of urinary biopyrrins and 8-hydroxydeoxyguanosine (8-OHdG), as measured by enzyme-linked immunosorbent assay, were normalized to the urinary concentration of creatinine. Psychiatric symptoms were assessed by the administration of the Brief Psychiatric Rating Scale (BPRS).
RESULTS: The concentration of biopyrrins in patients with chronic schizophrenia was significantly higher when compared with healthy volunteers. The correlation between biopyrrin level and the duration of illness was highly significant. There were no significant differences in the levels of urinary 8-OHdG between the two groups. In schizophrenic patients, the level of urinary biopyrrins showed correlations with BPRS scores, while the level of urinary 8-OHdG did not show correlations with BPRS.
CONCLUSIONS: Urinary biopyrrins are increased in patients with chronic schizophrenia while urinary 8-OHdG is not increased. These findings suggest that patients with chronic schizophrenia are under the condition of certain oxidative stresses.
© 2015 The Authors. Psychiatry and Clinical Neurosciences © 2015 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  8-hydroxydeoxyguanosine; biopyrrins; chronic schizophrenia; oxidative stress markers; reactive oxygen species; urine

Mesh:

Substances:

Year:  2015        PMID: 25975810     DOI: 10.1111/pcn.12319

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  NADPH-oxidase 4 gene over-expression in peripheral blood lymphocytes of the schizophrenia patients.

Authors:  Elizaveta S Ershova; Galina V Shmarina; Andrey V Martynov; Natalia V Zakharova; Roman V Veiko; Pavel E Umriukhin; George P Kostyuk; Sergey I Kutsev; Natalia N Veiko; Svetlana V Kostyuk
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

2.  Natural reduced water suppressed anxiety and protected the heightened oxidative stress in rats.

Authors:  Koji Masuda; Yoshihiro Tanaka; Masayuki Kanehisa; Taiga Ninomiya; Ayako Inoue; Haruka Higuma; Chiwa Kawashima; Mari Nakanishi; Kana Okamoto; Jotaro Akiyoshi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-08       Impact factor: 2.570

Review 3.  Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia.

Authors:  D A Maas; A Vallès; G J M Martens
Journal:  Transl Psychiatry       Date:  2017-07-18       Impact factor: 6.222

4.  Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis.

Authors:  Meneca Becklén; Funda Orhan; Fredrik Piehl; Simon Cervenka; Carl M Sellgren; Lena Flyckt; Sophie Erhardt; Helena Fatouros-Bergman
Journal:  Sci Rep       Date:  2021-04-06       Impact factor: 4.379

Review 5.  Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway.

Authors:  Alexandre Vallée
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

6.  Reference urinary biopyrrin level and physiological variation in healthy young adults: relation of stress by learning.

Authors:  Satoshi Tada; Atsuko Shiota; Hidehiro Hayashi; Takehiro Nakamura
Journal:  Heliyon       Date:  2020-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.